Bottom line
Is NQVAX a good fund? The bottom line
NQVAX is a share class of Nuveen Multi Cap Value Fund, a managed large value mutual fund from Nuveen / TIAA.
It charges 1.09% — about $109 a year on every $10,000 invested, more expensive than 72% of large value funds we track.
It returned +10.9% over one year, +14.1% a year over five years, +11.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.3 billion in net assets and 63 holdings, its largest position is Amazon.com Inc (3.6%) and the top 10 make up 29.4% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 94% of category peers
What to watch
- Expensive for its category (1.09%)
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What NQVAX invests in
The investment objective of the Fund is to provide investors with long-term capital appreciation.
Under normal circumstances, the Fund invests at least 80% of the sum of its net assets and the amount of any borrowings for investment purposes in equity securities of value companies. Value companies are those that are constituents of at least one of the following indexes on the last business day of the month in which its most recent reconstitution was completed (as adjusted by changes to an index between reconstitutions): Russell 3000 Value Index, S&P 1500 Value Index and MSCI World IMI Value Index. The Fund may invest in equity securities issued by companies with small, mid and large capitalizations. The Funds sub-adviser seeks to identify under-valued companies with a catalyst to unlock value or improve profitability. The Funds sub-adviser maintains a long-term investment view and a focus on securities it believes can appreciate over an extended time, regardless of interim…
From the fund's prospectus (filed Oct 28, 2026).
NQVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| NQVAX | +10.9% | +14.1% | +11.2% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What NQVAX costs
On a $10,000 investment, NQVAX's 1.09% expense ratio costs about $109 a year. The prospectus estimates $1,902 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
NQVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Amazon.com Inc | 3.65% |
| 2 | Intel Corp | 3.49% |
| 3 | Citigroup Inc | 3.29% |
| 4 | Regal Rexnord Corp | 3.19% |
| 5 | Viasat Inc | 3.02% |
| 6 | Flowserve Corp | 2.80% |
| 7 | Wells Fargo & Co | 2.66% |
| 8 | Cheniere Energy Inc | 2.49% |
| 9 | Capital One Financial Corp | 2.46% |
| 10 | Alphabet Inc | 2.30% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 29.4% of the fund. See all top 25 holdings and asset mix →